Skip to main content
Cannabotech Ltd. logo

Cannabotech Ltd. — Investor Relations & Filings

Ticker · CNTC ISIN · IL0011769085 TA Manufacturing
Open in API
Filings indexed 15 across all filing types
Latest filing 2025-12-03 Regulatory Filings
Country IL Israel
Listing TA CNTC

About Cannabotech Ltd.

https://www.cannabotech.com/

Cannabotech Ltd. is a biomedical company developing therapeutic solutions by integrating cannabinoids and medicinal mushroom extracts. The company's activities encompass both pharmaceutical development and consumer wellness. Its pharmaceutical research focuses on treatments for oncology and inflammatory diseases. Concurrently, Cannabotech markets a consumer product line based on its proprietary M2CBD formula, which synergistically combines highly bioavailable CBD with patented functional mushroom varieties. These supplements and topical products are formulated to support immunity, sleep, and stress management, promoting a preventative approach to health and well-being.

Recent filings

Filing Released Lang Actions
Changes in the company's name and security's name, effective as of December 7, 2025
Regulatory Filings Classification · 95% confidence The document is a short notice from the Tel Aviv Stock Exchange (TASE) informing members about a corporate name change for Cannabotech Ltd to PSYRX CNS BIO-TECH LTD and the corresponding updates to security identifiers. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding listing details, it falls under the RNS (Regulatory Filings) category.
2025-12-03 English
Base price of 1 agora and unlimited price fluctuation
Capital/Financing Update Classification · 95% confidence The document is a short announcement from the Tel Aviv Stock Exchange regarding the trading details of CANNABOTECH shares following a large placement. It specifies the base price and price fluctuation for the stock on a particular trading day. There is no detailed financial data, no report attached or referenced, and no regulatory filing or certification. This is an update related to capital market activity, specifically about trading terms after a capital event (large placement). Therefore, it fits best under Capital/Financing Update (CAP). The document length is very short and purely informational about trading conditions, not a report or announcement of voting or management changes.
2025-02-10 Hebrew (modern)
Capital consolidation 10:1, There will be no trading in the company's shares on January 20, 2025, which is the record date for the capital consolidation
Capital/Financing Update Classification · 95% confidence The document is a notice from the Tel Aviv Stock Exchange regarding a capital consolidation (reverse stock split) of Cannabotech Ltd shares, specifying the ratio (10:1), record date, and trading suspension on the record date. It is an announcement about a capital structure change, not a full financial report or detailed filing. The document length is short (837 characters), consistent with a brief announcement. Therefore, it fits the category of Capital/Financing Update (CAP).
2025-01-09 Hebrew (modern)
Trading in the company's shares (ISIN IL0011769085) will be renewed on Thursday , November 14, 2024, on the main list
Report Publication Announcement Classification · 95% confidence The document is a short notice from the Tel-Aviv Stock Exchange regarding the renewal of trading for Cannabotec shares after the company published its second quarter 2024 financial statements. It does not contain the financial statements themselves but announces the resumption of trading following their publication. The document length is only 691 characters, indicating it is an announcement rather than a full financial report. According to the 'Menu vs Meal' rule, this is a report publication announcement or regulatory announcement rather than the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2024-11-12 Hebrew (modern)
Suspension due to failure in publication of financial reports
Delisting Announcement Classification · 95% confidence The document is a notice from the Tel Aviv Stock Exchange (TASE) regarding the suspension of trading of Cannabotech shares due to failure to publish financial reports. It mentions regulatory rules about suspension and potential delisting but does not contain any financial data or the financial reports themselves. The document is short (971 characters) and serves as an official announcement about trading suspension and potential delisting. Therefore, it fits the category of a Delisting Announcement (DLST).
2024-10-01 Hebrew (modern)
CANNABOTECH– Appointment of a Market Maker
Regulatory Filings Classification · 95% confidence The document is a short announcement notifying the appointment of a market maker for a specific security. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory announcement related to trading and market operations rather than a financial report or management update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-29 Hebrew (modern)

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.